Preclinical assessment of iodantipyrine safety

A. S. Saratikov, T. P. Novozheeva, N. S. Livshits, F. I. Burchenkova, N. G. Kadychagova, R. R. Akhmedzhanov, L. V. Bashirova, A. A. Eremina, G. V. Potapova

Отделение контроля и диагностики

Результат исследований: Материалы для журнала › Статья › рецензирование

Аннотация

Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD₅₀ parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

Язык оригинала	Английский
Число страниц	1
Журнал	Eksperimental'naya i Klinicheskaya Farmakologiya
Том	61
Номер выпуска	2
Состояние	Опубликовано - 1 янв 1998

ASJC Scopus subject areas

Toxicology
Pharmacology

Другие файлы и ссылки

Fingerprint Подробные сведения о темах исследования «Preclinical assessment of iodantipyrine safety». Вместе они формируют уникальный семантический отпечаток (fingerprint).

Цитировать

Preclinical assessment of iodantipyrine safety. / Saratikov, A. S.; Novozheeva, T. P.; Livshits, N. S.; Burchenkova, F. I.; Kadychagova, N. G.; Akhmedzhanov, R. R.; Bashirova, L. V.; Eremina, A. A.; Potapova, G. V.

В: Eksperimental'naya i Klinicheskaya Farmakologiya, Том 61, № 2, 01.01.1998.

Результат исследований: Материалы для журнала › Статья › рецензирование

@article{57376dd88ec044c5a66e3688512f599c,

title = "Preclinical assessment of iodantipyrine safety",

abstract = "Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.",

author = "Saratikov, {A. S.} and Novozheeva, {T. P.} and Livshits, {N. S.} and Burchenkova, {F. I.} and Kadychagova, {N. G.} and Akhmedzhanov, {R. R.} and Bashirova, {L. V.} and Eremina, {A. A.} and Potapova, {G. V.}",

year = "1998",

month = jan,

day = "1",

language = "English",

volume = "61",

journal = "Eksperimental'naya i Klinicheskaya Farmakologiya",

issn = "0869-2092",

publisher = "Izdatelstvo Meditsina",

number = "2",

}

TY - JOUR

T1 - Preclinical assessment of iodantipyrine safety

AU - Saratikov, A. S.

AU - Novozheeva, T. P.

AU - Livshits, N. S.

AU - Burchenkova, F. I.

AU - Kadychagova, N. G.

AU - Akhmedzhanov, R. R.

AU - Bashirova, L. V.

AU - Eremina, A. A.

AU - Potapova, G. V.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

AB - Detailed preclinical study of the safety of the new antiviral agent iodantipyrine was conducted. In LD50 parameters it was found to be related to moderately toxic drugs. Long-term administration in doses of 50, 100, and 250 mg/kg did not cause any essential functional and structural disorders in the organs and systems of rats and dogs. Iodantipyrine does not possess mutagenic and allergenic properties and does not affect the reproductive function.

UR - http://www.scopus.com/inward/record.url?scp=0347718487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347718487&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0347718487

VL - 61

JO - Eksperimental'naya i Klinicheskaya Farmakologiya

JF - Eksperimental'naya i Klinicheskaya Farmakologiya

SN - 0869-2092

IS - 2

ER -